Carl E. Allen, Ph.D. - Publications

2000 Ohio State University, Columbus, Columbus, OH 
Molecular Biology, Cell Biology, Oncology

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Allen CE. ALPS DNT cells: active senior living with mTOR. Blood. 128: 152. PMID 27418624 DOI: 10.1182/blood-2016-05-713032  0.96
2016 Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, et al. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes. Cancer. PMID 27244347 DOI: 10.1002/cncr.30084  0.96
2016 Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Gil Herrera J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. PMID 26966089 DOI: 10.1182/blood-2016-01-690636  0.96
2016 Zinn DJ, Chakraborty R, Allen CE. Langerhans cell histiocytosis: Emerging insights and clinical implications Oncology (United States). 30.  0.96
2015 Collin M, Bigley V, McClain KL, Allen CE. Cell(s) of Origin of Langerhans Cell Histiocytosis. Hematology/Oncology Clinics of North America. 29: 825-38. PMID 26461145 DOI: 10.1016/j.hoc.2015.06.003  0.96
2015 Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 126: 26-35. PMID 25827831 DOI: 10.1182/blood-2014-12-569301  0.96
2015 Allen CE, McClain KL. Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-Galindo. British Journal of Haematology. PMID 25817049 DOI: 10.1111/bjh.13371  0.96
2015 Allen CE, Kelly KM, Bollard CM. Pediatric lymphomas and histiocytic disorders of childhood. Pediatric Clinics of North America. 62: 139-65. PMID 25435117 DOI: 10.1016/j.pcl.2014.09.010  0.96
2015 Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? British Journal of Haematology. 169: 3-13. PMID 25430560 DOI: 10.1111/bjh.13247  0.96
2015 Simko SJ, McClain KL, Allen CE. Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone? British Journal of Haematology. 169: 299-301. PMID 25400231 DOI: 10.1111/bjh.13208  0.96
2014 Simko SJ, Garmezy B, Abhyankar H, Lupo PJ, Chakraborty R, Lim KP, Shih A, Hicks MJ, Wright TS, Levy ML, McClain KL, Allen CE. Differentiating skin-limited and multisystem Langerhans cell histiocytosis. The Journal of Pediatrics. 165: 990-6. PMID 25441388 DOI: 10.1016/j.jpeds.2014.07.063  0.96
2014 Allen CE, McClain KL. fHLH: becoming a blended family. Blood. 124: 1210-1. PMID 25147377 DOI: 10.1182/blood-2014-06-582791  0.96
2014 Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 61: 2101-3. PMID 24753034 DOI: 10.1002/pbc.25058  0.96
2014 Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, ... ... Allen CE, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 211: 669-83. PMID 24638167 DOI: 10.1084/jem.20130977  0.96
2014 Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatric Blood & Cancer. 61: 1329-35. PMID 24610771 DOI: 10.1002/pbc.25017  0.96
2014 Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, ... ... Allen CE, et al. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatric Blood & Cancer. 61: 479-87. PMID 24106153 DOI: 10.1002/pbc.24772  0.96
2013 Berres ML, Allen CE, Merad M. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Advances in Immunology. 120: 127-61. PMID 24070383 DOI: 10.1016/B978-0-12-417028-5.00005-3  0.96
2013 Slater BJ, Nordin AB, Allen CE, Elghetany MT, Heinle JS, Kim ES. Resection of mediastinal castleman's disease: a case report. Pediatric Hematology and Oncology. 30: 554-6. PMID 23301538 DOI: 10.3109/08880018.2012.753494  0.96
2013 Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatric Blood & Cancer. 60: 101-9. PMID 22522603 DOI: 10.1002/pbc.24188  0.96
2012 Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. Plos One. 7: e43257. PMID 22916233 DOI: 10.1371/journal.pone.0043257  0.96
2012 Rathore N, Eissa HM, Margolin JF, Liu H, Wu MF, Horton T, Kamdar K, Dreyer Z, Steuber P, Rabin KR, Redell M, Allen CE, McClain KL, Guillerman RP, Bollard CM. Pediatric Hodgkin lymphoma: are we over-scanning our patients? Pediatric Hematology and Oncology. 29: 415-23. PMID 22632168 DOI: 10.3109/08880018.2012.684198  0.96
2011 Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 118: 4041-52. PMID 21828139 DOI: 10.1182/blood-2011-03-278127  0.96
2011 Peters TL, McClain KL, Allen CE. Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1433-9. PMID 21654633 DOI: 10.1038/mt.2011.106  0.96
2011 Allen CE, McClain KL. Erdheim-Chester: beyond the lesion. Blood. 117: 2745-6. PMID 21393495 DOI: 10.1182/blood-2011-01-330233  0.96
2011 Liu S, Madiai F, Hackshaw KV, Allen CE, Carl J, Huschart E, Karanfilov C, Litsky A, Hickey CJ, Marcucci G, Huja S, Agarwal S, Yu J, Caligiuri MA, Wu LC. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis. Plos One. 6: e17161. PMID 21390242 DOI: 10.1371/journal.pone.0017161  0.96
2011 Allen CE. Diagnosing hemophagocytic lymphohistiocytosis: sheep vs. wolf. Pediatric Hematology and Oncology. 28: 173-5. PMID 21381868 DOI: 10.3109/08880018.2011.563997  0.96
2011 Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatric Blood & Cancer. 56: 154-5. PMID 20842751 DOI: 10.1002/pbc.22774  0.96
2011 Yakovich AJ, Jiang B, Allen CE, Du J, Wu LC, Barnard JA. ZAS3 accentuates transforming growth factor β signaling in epithelial cells. Cellular Signalling. 23: 105-13. PMID 20732416 DOI: 10.1016/j.cellsig.2010.08.009  0.96
2010 Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, Merad M, McClain KL. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 4557-67. PMID 20220088 DOI: 10.4049/jimmunol.0902336  0.96
2010 Allen CE, Flores R, Rauch R, Dauser R, Murray JC, Puccetti D, Hsu DA, Sondel P, Hetherington M, Goldman S, McClain KL. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside Pediatric Blood and Cancer. 54: 416-423. PMID 19908293 DOI: 10.1002/pbc.22326  0.96
2009 Allen CE, McClain KL. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nature Medicine. 15: 483-4; author reply . PMID 19424201 DOI: 10.1038/nm0509-483  0.96
2009 Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA, McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 52: 621-5. PMID 19137570 DOI: 10.1002/pbc.21838  0.96
2009 Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatric Blood & Cancer. 52: 97-101. PMID 18951435 DOI: 10.1002/pbc.21782  0.96
2008 Allen CE, Du J, Jiang B, Huang Q, Yakovich AJ, Barnard JA. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells. Neoplasia (New York, N.Y.). 10: 1073-82. PMID 18813357  0.32
2008 Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 50: 1227-35. PMID 18085676 DOI: 10.1002/pbc.21423  0.96
2008 Allen CE, McClain KL. Hemophagocytic lymphohistiocytosis Paediatrics and Child Health. 18: 136-140. DOI: 10.1016/j.paed.2007.12.009  0.96
2008 Allen C, McClain K, Filipovich L. Highly elevated ferritin levels and the diagnosis of HLH/sepsis/SIRS/MODS/ MAS - Response Pediatric Blood and Cancer. 51: 710-711. DOI: 10.1002/pbc.21679  0.96
2008 McClain KL, Allen CE, Kozinetz C. Response to "distinguishing hemophagocytic lymphohistiocytosis from hemochromatosis in patients with hyperferritinemia", Pediatric Blood and Cancer. 50: 1287-1288. DOI: 10.1002/pbc.21541  0.96
2007 Allen CE, Richards J, Muthusamy N, Auer H, Liu Y, Robinson ML, Barnard JA, Wu LC. Disruption of ZAS3 in mice alters NF-kappaB and AP-1 DNA binding and T-cell development. Gene Expression. 14: 83-100. PMID 18257392 DOI: 10.3727/105221607783417574  0.96
2007 Allen CE, McClain KL. Langerhans cell histiocytosis: a review of past, current and future therapies. Drugs of Today (Barcelona, Spain : 1998). 43: 627-43. PMID 17940639 DOI: 10.1358/dot.2007.43.9.1088823  0.96
2006 Cull WL, Mulvey HJ, Jewett EA, Zalneraitis EL, Allen CE, Pan RJ. Pediatric residency duty hours before and after limitations. Pediatrics. 118: e1805-11. PMID 17142502 DOI: 10.1542/peds.2006-0210  0.96
2003 Hong JW, Allen CE, Wu LC. Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motif. Proceedings of the National Academy of Sciences of the United States of America. 100: 12301-6. PMID 14530385 DOI: 10.1073/pnas.2133048100  0.96
2002 Robinson ML, Allen CE, Davy BE, Durfee WJ, Elder FF, Elliott CS, Harrison WR. Genetic mapping of an insertional hydrocephalus-inducing mutation allelic to hy3. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 13: 625-32. PMID 12461648 DOI: 10.1007/s00335-002-2201-8  0.96
2002 Allen CE, Muthusamy N, Weisbrode SE, Hong JW, Wu LC. Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC. Genes, Chromosomes & Cancer. 35: 287-98. PMID 12378523 DOI: 10.1002/gcc.10128  0.96
2002 Allen CE, Mak CH, Wu LC. The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study. Bmc Immunology. 3: 10. PMID 12193271 DOI: 10.1186/1471-2172-3-10  0.96
2001 Wu LC, Hicar MD, Hong J, Allen CE. The DNA-binding ability of HIVEP3/KRC decreases upon activation of V(D)J recombination. Immunogenetics. 53: 564-71. PMID 11685469 DOI: 10.1007/s002510100360  0.96
2001 Hicar MD, Liu Y, Allen CE, Wu LC. Structure of the human zinc finger protein HIVEP3: molecular cloning, expression, exon-intron structure, and comparison with paralogous genes HIVEP1 and HIVEP2. Genomics. 71: 89-100. PMID 11161801 DOI: 10.1006/geno.2000.6425  0.96
2000 Allen CE, Wu LC. Downregulation of KRC induces proliferation, anchorage independence, and mitotic cell death in HeLa cells. Experimental Cell Research. 260: 346-56. PMID 11035930 DOI: 10.1006/excr.2000.5029  0.96
2000 Hjelmsoe I, Allen CE, Cohn MA, Tulchinsky EM, Wu LC. The kappaB and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1. The Journal of Biological Chemistry. 275: 913-20. PMID 10625627 DOI: 10.1074/jbc.275.2.913  0.96
1998 Mak CH, Li Z, Allen CE, Liu Y, Wu LC. KRC transcripts: Identification of an unusual alternative splicing event Immunogenetics. 48: 32-39. PMID 9601941 DOI: 10.1007/s002510050397  0.96
1998 Allen CE, Wu LC. KRC controls cell growth by regulating the transcription of c-myc Faseb Journal. 12.  0.96
Show low-probability matches.